James Miles
James undertook an industrial cotutelle PhD between Hawk Biosystems, the University of the Basque Country and the University of Bordeaux. During his doctoral studies, he sought to elucidate PD-1/PD-L1 as a prognostic biomarker in a range of solid tumours. James graduated in 2022 with his PhD and continued his full-time role as our Product Manager. Having worked with the QF-Pro® technology since 2015, he is well placed to oversee our current QF-Pro® product line, including Violet 3.0 and our QF-Pro® software and reagent kits.
Abstracts this author is presenting:
